Protara Therapeutics (TARA) Other Non-Current Liabilities (2013 - 2016)

Protara Therapeutics (TARA) has 4 years of Other Non-Current Liabilities data on file, last reported at $98000.0 in Q3 2016.

• On a quarterly basis, Other Non-Current Liabilities rose 16.67% year-over-year to $98000.0 in Q3 2016; TTM through Sep 2016 was $98000.0, a 16.67% increase from a year earlier, with the FY2015 full-year figure at $537000.0, changed N/A from the prior year.
• Other Non-Current Liabilities for Q3 2016 stood at $98000.0, down from $241000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for TARA reached as high as $11.9 million in Q3 2014 and fell as low as $51000.0 in Q2 2015.
• Historically, Other Non-Current Liabilities has averaged $1.8 million across 4 years, with a median of $280000.0 in 2016.
• Across the five-year window, Other Non-Current Liabilities tumbled 99.29% in 2015 and soared 372.55% in 2016, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.4 million in 2013, then surged by 724.88% to $11.9 million in 2014, then sank by 95.49% to $537000.0 in 2015, then slumped by 81.75% to $98000.0 in 2016.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $98000.0 in Q3 2016, $241000.0 in Q2 2016, and $319000.0 in Q1 2016.